Novel Vaccine Delivery Systems Market, Global Outlook and Forecast 2022-2028

April 2022 | 68 pages | ID: N059A3D4DA89EN
Market Monitor Global

Abstracts

Novel vaccine delivery includes formulations, technologies, methods, and systems to transfer an active pharmaceutical ingredient in the body, as desired, in order to safely accomplish its therapeutic effect.

This report contains market size and forecasts of Novel Vaccine Delivery Systems in Global, including the following market information:

Global Novel Vaccine Delivery Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Novel Vaccine Delivery Systems market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Intramuscular Delivery Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Novel Vaccine Delivery Systems include Altaris Capital Partners, Kindeva Drug Delivery, Becton, Dickinson,, Carl Zeiss Foundation, Gerresheimer AG, Corium International, Inovio Pharmaceuticals and Bioject Medical Technologies, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Novel Vaccine Delivery Systems companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Novel Vaccine Delivery Systems Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Novel Vaccine Delivery Systems Market Segment Percentages, by Type, 2021 (%)

• Intramuscular Delivery
• Intramuscular Delivery
• Others

Global Novel Vaccine Delivery Systems Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Novel Vaccine Delivery Systems Market Segment Percentages, by Application, 2021 (%)

• Hospitals & Clinics
• Research Institutes
• Others

Global Novel Vaccine Delivery Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Novel Vaccine Delivery Systems Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Novel Vaccine Delivery Systems revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Novel Vaccine Delivery Systems revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Altaris Capital Partners
• Kindeva Drug Delivery
• Becton
• Dickinson,
• Carl Zeiss Foundation
• Gerresheimer AG
• Corium International
• Inovio Pharmaceuticals
• Bioject Medical Technologies
• PharmaJet
• Retractable Technologies
• Terumo Corporation
• VAXXAS

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Novel Vaccine Delivery Systems Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Novel Vaccine Delivery Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NOVEL VACCINE DELIVERY SYSTEMS OVERALL MARKET SIZE

2.1 Global Novel Vaccine Delivery Systems Market Size: 2021 VS 2028
2.2 Global Novel Vaccine Delivery Systems Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Novel Vaccine Delivery Systems Players in Global Market
3.2 Top Global Novel Vaccine Delivery Systems Companies Ranked by Revenue
3.3 Global Novel Vaccine Delivery Systems Revenue by Companies
3.4 Top 3 and Top 5 Novel Vaccine Delivery Systems Companies in Global Market, by Revenue in 2021
3.5 Global Companies Novel Vaccine Delivery Systems Product Type
3.6 Tier 1, Tier 2 and Tier 3 Novel Vaccine Delivery Systems Players in Global Market
  3.6.1 List of Global Tier 1 Novel Vaccine Delivery Systems Companies
  3.6.2 List of Global Tier 2 and Tier 3 Novel Vaccine Delivery Systems Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Novel Vaccine Delivery Systems Market Size Markets, 2021 & 2028
  4.1.2 Intramuscular Delivery
  4.1.3 Intramuscular Delivery
  4.1.4 Others
4.2 By Type - Global Novel Vaccine Delivery Systems Revenue & Forecasts
  4.2.1 By Type - Global Novel Vaccine Delivery Systems Revenue, 2017-2022
  4.2.2 By Type - Global Novel Vaccine Delivery Systems Revenue, 2023-2028
  4.2.3 By Type - Global Novel Vaccine Delivery Systems Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Novel Vaccine Delivery Systems Market Size, 2021 & 2028
  5.1.2 Hospitals & Clinics
  5.1.3 Research Institutes
  5.1.4 Others
5.2 By Application - Global Novel Vaccine Delivery Systems Revenue & Forecasts
  5.2.1 By Application - Global Novel Vaccine Delivery Systems Revenue, 2017-2022
  5.2.2 By Application - Global Novel Vaccine Delivery Systems Revenue, 2023-2028
  5.2.3 By Application - Global Novel Vaccine Delivery Systems Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Novel Vaccine Delivery Systems Market Size, 2021 & 2028
6.2 By Region - Global Novel Vaccine Delivery Systems Revenue & Forecasts
  6.2.1 By Region - Global Novel Vaccine Delivery Systems Revenue, 2017-2022
  6.2.2 By Region - Global Novel Vaccine Delivery Systems Revenue, 2023-2028
  6.2.3 By Region - Global Novel Vaccine Delivery Systems Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Novel Vaccine Delivery Systems Revenue, 2017-2028
  6.3.2 US Novel Vaccine Delivery Systems Market Size, 2017-2028
  6.3.3 Canada Novel Vaccine Delivery Systems Market Size, 2017-2028
  6.3.4 Mexico Novel Vaccine Delivery Systems Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Novel Vaccine Delivery Systems Revenue, 2017-2028
  6.4.2 Germany Novel Vaccine Delivery Systems Market Size, 2017-2028
  6.4.3 France Novel Vaccine Delivery Systems Market Size, 2017-2028
  6.4.4 U.K. Novel Vaccine Delivery Systems Market Size, 2017-2028
  6.4.5 Italy Novel Vaccine Delivery Systems Market Size, 2017-2028
  6.4.6 Russia Novel Vaccine Delivery Systems Market Size, 2017-2028
  6.4.7 Nordic Countries Novel Vaccine Delivery Systems Market Size, 2017-2028
  6.4.8 Benelux Novel Vaccine Delivery Systems Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Novel Vaccine Delivery Systems Revenue, 2017-2028
  6.5.2 China Novel Vaccine Delivery Systems Market Size, 2017-2028
  6.5.3 Japan Novel Vaccine Delivery Systems Market Size, 2017-2028
  6.5.4 South Korea Novel Vaccine Delivery Systems Market Size, 2017-2028
  6.5.5 Southeast Asia Novel Vaccine Delivery Systems Market Size, 2017-2028
  6.5.6 India Novel Vaccine Delivery Systems Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Novel Vaccine Delivery Systems Revenue, 2017-2028
  6.6.2 Brazil Novel Vaccine Delivery Systems Market Size, 2017-2028
  6.6.3 Argentina Novel Vaccine Delivery Systems Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Novel Vaccine Delivery Systems Revenue, 2017-2028
  6.7.2 Turkey Novel Vaccine Delivery Systems Market Size, 2017-2028
  6.7.3 Israel Novel Vaccine Delivery Systems Market Size, 2017-2028
  6.7.4 Saudi Arabia Novel Vaccine Delivery Systems Market Size, 2017-2028
  6.7.5 UAE Novel Vaccine Delivery Systems Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Altaris Capital Partners
  7.1.1 Altaris Capital Partners Corporate Summary
  7.1.2 Altaris Capital Partners Business Overview
  7.1.3 Altaris Capital Partners Novel Vaccine Delivery Systems Major Product Offerings
  7.1.4 Altaris Capital Partners Novel Vaccine Delivery Systems Revenue in Global Market (2017-2022)
  7.1.5 Altaris Capital Partners Key News
7.2 Kindeva Drug Delivery
  7.2.1 Kindeva Drug Delivery Corporate Summary
  7.2.2 Kindeva Drug Delivery Business Overview
  7.2.3 Kindeva Drug Delivery Novel Vaccine Delivery Systems Major Product Offerings
  7.2.4 Kindeva Drug Delivery Novel Vaccine Delivery Systems Revenue in Global Market (2017-2022)
  7.2.5 Kindeva Drug Delivery Key News
7.3 Becton
  7.3.1 Becton Corporate Summary
  7.3.2 Becton Business Overview
  7.3.3 Becton Novel Vaccine Delivery Systems Major Product Offerings
  7.3.4 Becton Novel Vaccine Delivery Systems Revenue in Global Market (2017-2022)
  7.3.5 Becton Key News
7.4 Dickinson,
  7.4.1 Dickinson, Corporate Summary
  7.4.2 Dickinson, Business Overview
  7.4.3 Dickinson, Novel Vaccine Delivery Systems Major Product Offerings
  7.4.4 Dickinson, Novel Vaccine Delivery Systems Revenue in Global Market (2017-2022)
  7.4.5 Dickinson, Key News
7.5 Carl Zeiss Foundation
  7.5.1 Carl Zeiss Foundation Corporate Summary
  7.5.2 Carl Zeiss Foundation Business Overview
  7.5.3 Carl Zeiss Foundation Novel Vaccine Delivery Systems Major Product Offerings
  7.5.4 Carl Zeiss Foundation Novel Vaccine Delivery Systems Revenue in Global Market (2017-2022)
  7.5.5 Carl Zeiss Foundation Key News
7.6 Gerresheimer AG
  7.6.1 Gerresheimer AG Corporate Summary
  7.6.2 Gerresheimer AG Business Overview
  7.6.3 Gerresheimer AG Novel Vaccine Delivery Systems Major Product Offerings
  7.6.4 Gerresheimer AG Novel Vaccine Delivery Systems Revenue in Global Market (2017-2022)
  7.6.5 Gerresheimer AG Key News
7.7 Corium International
  7.7.1 Corium International Corporate Summary
  7.7.2 Corium International Business Overview
  7.7.3 Corium International Novel Vaccine Delivery Systems Major Product Offerings
  7.7.4 Corium International Novel Vaccine Delivery Systems Revenue in Global Market (2017-2022)
  7.7.5 Corium International Key News
7.8 Inovio Pharmaceuticals
  7.8.1 Inovio Pharmaceuticals Corporate Summary
  7.8.2 Inovio Pharmaceuticals Business Overview
  7.8.3 Inovio Pharmaceuticals Novel Vaccine Delivery Systems Major Product Offerings
  7.8.4 Inovio Pharmaceuticals Novel Vaccine Delivery Systems Revenue in Global Market (2017-2022)
  7.8.5 Inovio Pharmaceuticals Key News
7.9 Bioject Medical Technologies
  7.9.1 Bioject Medical Technologies Corporate Summary
  7.9.2 Bioject Medical Technologies Business Overview
  7.9.3 Bioject Medical Technologies Novel Vaccine Delivery Systems Major Product Offerings
  7.9.4 Bioject Medical Technologies Novel Vaccine Delivery Systems Revenue in Global Market (2017-2022)
  7.9.5 Bioject Medical Technologies Key News
7.10 PharmaJet
  7.10.1 PharmaJet Corporate Summary
  7.10.2 PharmaJet Business Overview
  7.10.3 PharmaJet Novel Vaccine Delivery Systems Major Product Offerings
  7.10.4 PharmaJet Novel Vaccine Delivery Systems Revenue in Global Market (2017-2022)
  7.10.5 PharmaJet Key News
7.11 Retractable Technologies
  7.11.1 Retractable Technologies Corporate Summary
  7.11.2 Retractable Technologies Business Overview
  7.11.3 Retractable Technologies Novel Vaccine Delivery Systems Major Product Offerings
  7.11.4 Retractable Technologies Novel Vaccine Delivery Systems Revenue in Global Market (2017-2022)
  7.11.5 Retractable Technologies Key News
7.12 Terumo Corporation
  7.12.1 Terumo Corporation Corporate Summary
  7.12.2 Terumo Corporation Business Overview
  7.12.3 Terumo Corporation Novel Vaccine Delivery Systems Major Product Offerings
  7.12.4 Terumo Corporation Novel Vaccine Delivery Systems Revenue in Global Market (2017-2022)
  7.12.5 Terumo Corporation Key News
7.13 VAXXAS
  7.13.1 VAXXAS Corporate Summary
  7.13.2 VAXXAS Business Overview
  7.13.3 VAXXAS Novel Vaccine Delivery Systems Major Product Offerings
  7.13.4 VAXXAS Novel Vaccine Delivery Systems Revenue in Global Market (2017-2022)
  7.13.5 VAXXAS Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Novel Vaccine Delivery Systems Market Opportunities & Trends in Global Market
Table 2. Novel Vaccine Delivery Systems Market Drivers in Global Market
Table 3. Novel Vaccine Delivery Systems Market Restraints in Global Market
Table 4. Key Players of Novel Vaccine Delivery Systems in Global Market
Table 5. Top Novel Vaccine Delivery Systems Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Novel Vaccine Delivery Systems Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Novel Vaccine Delivery Systems Revenue Share by Companies, 2017-2022
Table 8. Global Companies Novel Vaccine Delivery Systems Product Type
Table 9. List of Global Tier 1 Novel Vaccine Delivery Systems Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Novel Vaccine Delivery Systems Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Novel Vaccine Delivery Systems Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Novel Vaccine Delivery Systems Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Novel Vaccine Delivery Systems Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Novel Vaccine Delivery Systems Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Novel Vaccine Delivery Systems Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Novel Vaccine Delivery Systems Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2023-2028
Table 30. Altaris Capital Partners Corporate Summary
Table 31. Altaris Capital Partners Novel Vaccine Delivery Systems Product Offerings
Table 32. Altaris Capital Partners Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 33. Kindeva Drug Delivery Corporate Summary
Table 34. Kindeva Drug Delivery Novel Vaccine Delivery Systems Product Offerings
Table 35. Kindeva Drug Delivery Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 36. Becton Corporate Summary
Table 37. Becton Novel Vaccine Delivery Systems Product Offerings
Table 38. Becton Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 39. Dickinson, Corporate Summary
Table 40. Dickinson, Novel Vaccine Delivery Systems Product Offerings
Table 41. Dickinson, Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 42. Carl Zeiss Foundation Corporate Summary
Table 43. Carl Zeiss Foundation Novel Vaccine Delivery Systems Product Offerings
Table 44. Carl Zeiss Foundation Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 45. Gerresheimer AG Corporate Summary
Table 46. Gerresheimer AG Novel Vaccine Delivery Systems Product Offerings
Table 47. Gerresheimer AG Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 48. Corium International Corporate Summary
Table 49. Corium International Novel Vaccine Delivery Systems Product Offerings
Table 50. Corium International Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 51. Inovio Pharmaceuticals Corporate Summary
Table 52. Inovio Pharmaceuticals Novel Vaccine Delivery Systems Product Offerings
Table 53. Inovio Pharmaceuticals Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 54. Bioject Medical Technologies Corporate Summary
Table 55. Bioject Medical Technologies Novel Vaccine Delivery Systems Product Offerings
Table 56. Bioject Medical Technologies Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 57. PharmaJet Corporate Summary
Table 58. PharmaJet Novel Vaccine Delivery Systems Product Offerings
Table 59. PharmaJet Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 60. Retractable Technologies Corporate Summary
Table 61. Retractable Technologies Novel Vaccine Delivery Systems Product Offerings
Table 62. Retractable Technologies Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 63. Terumo Corporation Corporate Summary
Table 64. Terumo Corporation Novel Vaccine Delivery Systems Product Offerings
Table 65. Terumo Corporation Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)
Table 66. VAXXAS Corporate Summary
Table 67. VAXXAS Novel Vaccine Delivery Systems Product Offerings
Table 68. VAXXAS Novel Vaccine Delivery Systems Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Novel Vaccine Delivery Systems Segment by Type in 2021
Figure 2. Novel Vaccine Delivery Systems Segment by Application in 2021
Figure 3. Global Novel Vaccine Delivery Systems Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Novel Vaccine Delivery Systems Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Novel Vaccine Delivery Systems Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Novel Vaccine Delivery Systems Revenue in 2021
Figure 8. By Type - Global Novel Vaccine Delivery Systems Revenue Market Share, 2017-2028
Figure 9. By Application - Global Novel Vaccine Delivery Systems Revenue Market Share, 2017-2028
Figure 10. By Region - Global Novel Vaccine Delivery Systems Revenue Market Share, 2017-2028
Figure 11. By Country - North America Novel Vaccine Delivery Systems Revenue Market Share, 2017-2028
Figure 12. US Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Novel Vaccine Delivery Systems Revenue Market Share, 2017-2028
Figure 16. Germany Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 17. France Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Novel Vaccine Delivery Systems Revenue Market Share, 2017-2028
Figure 24. China Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 28. India Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Novel Vaccine Delivery Systems Revenue Market Share, 2017-2028
Figure 30. Brazil Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Novel Vaccine Delivery Systems Revenue Market Share, 2017-2028
Figure 33. Turkey Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Novel Vaccine Delivery Systems Revenue, (US$, Mn), 2017-2028
Figure 37. Altaris Capital Partners Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Kindeva Drug Delivery Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Becton Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Dickinson, Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Carl Zeiss Foundation Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Gerresheimer AG Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Corium International Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Inovio Pharmaceuticals Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bioject Medical Technologies Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. PharmaJet Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Retractable Technologies Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Terumo Corporation Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. VAXXAS Novel Vaccine Delivery Systems Revenue Year Over Year Growth (US$, Mn) & (2017-2022)